These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
11938 related items for PubMed ID: 11241258
1. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Goggins WB, Finkelstein DM, Tsao H. Cancer; 2001 Feb 15; 91(4):874-80. PubMed ID: 11241258 [Abstract] [Full Text] [Related]
2. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM. J Clin Oncol; 2015 Oct 01; 33(28):3096-104. PubMed ID: 26240221 [Abstract] [Full Text] [Related]
3. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM. J Natl Cancer Inst; 2018 Nov 01; 110(11):1248-1258. PubMed ID: 29659938 [Abstract] [Full Text] [Related]
4. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP, Clarke CA, Aroner S, Swetter SM. J Am Acad Dermatol; 2010 May 01; 62(5):757-67. PubMed ID: 20223559 [Abstract] [Full Text] [Related]
5. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM. Blood Adv; 2019 Jul 09; 3(13):1961-1969. PubMed ID: 31262739 [Abstract] [Full Text] [Related]
6. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Arch Dermatol; 2007 Jan 09; 143(1):45-50. PubMed ID: 17224541 [Abstract] [Full Text] [Related]
8. A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma. Tsao H, Kwitkiwski K, Sober AJ. J Am Acad Dermatol; 2002 Jan 09; 46(1):55-61. PubMed ID: 11756946 [Abstract] [Full Text] [Related]
10. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012). Baras N, Dahm S, Haberland J, Janz M, Emrich K, Kraywinkel K, Salama A. Br J Haematol; 2017 Apr 09; 177(2):226-242. PubMed ID: 28106907 [Abstract] [Full Text] [Related]
11. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. Hisada M, Chen BE, Jaffe ES, Travis LB. J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716 [Abstract] [Full Text] [Related]
13. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK. Cancer; 2006 Jul 01; 107(1):108-15. PubMed ID: 16708354 [Abstract] [Full Text] [Related]
16. Association between female breast cancer and cutaneous melanoma. Goggins W, Gao W, Tsao H. Int J Cancer; 2004 Sep 20; 111(5):792-4. PubMed ID: 15252852 [Abstract] [Full Text] [Related]
18. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up. Tadmor T, Liphshitz I, Silverman B, Polliack A. Hematol Oncol; 2017 Dec 20; 35(4):599-607. PubMed ID: 27238496 [Abstract] [Full Text] [Related]
19. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors. Xavier AC, Armeson KE, Hill EG, Costa LJ. Cancer; 2013 Sep 15; 119(18):3385-92. PubMed ID: 23797978 [Abstract] [Full Text] [Related]